1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders

2. Research Methodology

2.1. Research Process
2.1.1. Define: Research Objective
2.1.2. Determine: Research Design
2.1.3. Prepare: Research Instrument
2.1.4. Collect: Data Source
2.1.5. Analyze: Data Interpretation
2.1.6. Formulate: Data Verification
2.1.7. Publish: Research Report
2.1.8. Repeat: Report Update
2.2. Research Execution
2.2.1. Initiation: Research Process
2.2.2. Planning: Develop Research Plan
2.2.3. Execution: Conduct Research
2.2.4. Verification: Finding & Analysis
2.2.5. Publication: Research Report
2.3. Research Outcome

3. Executive Summary

3.1. Market Outlook
3.2. Form Outlook
3.3. End User Outlook
3.4. Geography Outlook
3.5. Competitor Outlook

4. Market Overview

4.1. Introduction

5. Market Dynamics

5.1. Introduction
5.2. Drivers
5.3. Restraints
5.4. Opportunities
5.5. Challenges

6. Market Insights

6.1. Porters Five Forces Analysis
6.1.1. Threat of New Entrants
6.1.2. Threat of Substitutes
6.1.3. Bargaining Power of Customers
6.1.4. Bargaining Power of Suppliers
6.1.5. Industry Rivalry
6.2. Cumulative Impact of COVID-19
6.3. Client Customizations

7. Global Type 1 Diabetes Drug Market, By Form

7.1. Introduction
7.2. Insulin Therapy
7.2.1. Long-Acting Insulin
7.2.2. Premix Analogs
7.2.3. Rapid Acting Insulin
7.3. Oral Medication
7.3.1. Biguanides
7.3.1.1. Metformine
7.3.1.2. Metformine Extended-Release
7.3.2. Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors
7.3.2.1. Canaglifozine
7.3.2.2. Dapagliflozine
7.3.2.3. Empagliflozine
7.3.2.4. Ertugliflozine

8. Global Type 1 Diabetes Drug Market, By End User

8.1. Introduction
8.2. Drugstore
8.3. Hospital

9. Global Type 1 Diabetes Drug Market, By Geography

9.1. Introduction
9.2. Americas
9.2.1. Argentina
9.2.2. Brazil
9.2.3. Canada
9.2.4. Mexico
9.2.5. United States
9.3. Asia-Pacific
9.3.1. Australia
9.3.2. China
9.3.3. India
9.3.4. Indonesia
9.3.5. Japan
9.3.6. Malaysia
9.3.7. Philippines
9.3.8. South Korea
9.3.9. Thailand
9.4. Europe, Middle East & Africa
9.4.1. France
9.4.2. Germany
9.4.3. Italy
9.4.4. Netherlands
9.4.5. Qatar
9.4.6. Russia
9.4.7. Saudi Arabia
9.4.8. South Africa
9.4.9. Spain
9.4.10. United Arab Emirates
9.4.11. United Kingdom

10. 360iResearch Competitive Strategic Window

10.1. Introduction
10.2. 360iResearch Competitive Strategic Window, by Form
10.3. 360iResearch Competitive Strategic Window, by End User
10.4. 360iResearch Competitive Strategic Window, by Geography

11. Competitive Landscape

11.1. 360iResearch FPNV Positioning Matrix
11.1.1. Quadrants
11.1.2. Business Strategy
11.1.3. Product Satisfaction
11.2. 360iResearch Market Ranking Analysis
11.3. 360iResearch Market Share Analysis
11.4. 360iResearch Competitive Scenario
11.4.1. Merger & Acquisition
11.4.2. Agreement, Collaboration, & Partnership
11.4.3. New Product Launch & Enhancement
11.4.4. Investment & Funding
11.4.5. Award, Recognition, & Expansion

12. Company Usability Profiles

12.1. Astellas Pharma Inc.
12.2. Astrazeneca Plc
12.3. B.braun Melsungen Ag
12.4. Biocon Limited
12.5. Biodel, Inc.
12.6. Diavacs, Inc.
12.7. Janssen Pharmaceutica
12.8. Macrogenics, Inc.
12.9. Merck & Co., Inc.
12.10. Mylan N.V.
12.11. Novo Nordisk A/s
12.12. Samsung Bioepis Co., Ltd.
12.13. Sanofi S.A.

13. Appendix

13.1. Discussion Guide
13.2. Edition Details
13.3. License Details
13.4. Pricing Details

List of Figures

FIGURE 1. GLOBAL TYPE 1 DIABETES DRUG MARKET: RESEARCH PROCESS
FIGURE 2. GLOBAL TYPE 1 DIABETES DRUG MARKET: RESEARCH EXECUTION
FIGURE 3. GLOBAL TYPE 1 DIABETES DRUG MARKET SIZE, 2019 VS 2025 (USD MILLION)
FIGURE 4. GLOBAL TYPE 1 DIABETES DRUG MARKET SIZE, BY FORM, 2019 VS 2025 (USD MILLION)
FIGURE 5. GLOBAL TYPE 1 DIABETES DRUG MARKET SIZE, BY END USER, 2019 VS 2025 (USD MILLION)
FIGURE 6. GLOBAL TYPE 1 DIABETES DRUG MARKET SIZE, BY GEOGRAPHY, 2019 VS 2025 (USD MILLION)
FIGURE 7. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL TYPE 1 DIABETES DRUG MARKET, BY TYPE
FIGURE 8. GLOBAL TYPE 1 DIABETES DRUG MARKET SIZE, 2017-2025 (USD MILLION)
FIGURE 9. GLOBAL TYPE 1 DIABETES DRUG MARKET SIZE GROWTH , 2017-2025 (USD MILLION)
FIGURE 10. GLOBAL TYPE 1 DIABETES DRUG MARKET: MARKET DYNAMICS
FIGURE 11. GLOBAL TYPE 1 DIABETES DRUG MARKET: PORTERS FIVE FORCES ANALYSIS
FIGURE 12. GLOBAL TYPE 1 DIABETES DRUG MARKET SIZE, BY FORM, 2019 VS 2025 (USD MILLION)
FIGURE 13. GLOBAL TYPE 1 DIABETES DRUG MARKET SIZE, BY END USER, 2019 VS 2025 (USD MILLION)
FIGURE 14. GLOBAL TYPE 1 DIABETES DRUG MARKET SIZE, BY GEOGRAPHY, 2019 VS 2025 (USD MILLION)
FIGURE 15. AMERICAS TYPE 1 DIABETES DRUG MARKET SIZE, BY GEOGRAPHY, 2019 VS 2025 (USD MILLION)
FIGURE 16. ASIA-PACIFIC TYPE 1 DIABETES DRUG MARKET SIZE, BY GEOGRAPHY, 2019 VS 2025 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA TYPE 1 DIABETES DRUG MARKET SIZE, BY GEOGRAPHY, 2019 VS 2025 (USD MILLION)
FIGURE 18. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL TYPE 1 DIABETES DRUG MARKET SIZE, BY FORM, 2025
FIGURE 19. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL TYPE 1 DIABETES DRUG MARKET SIZE, BY END USER, 2025
FIGURE 20. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL TYPE 1 DIABETES DRUG MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 21. GLOBAL TYPE 1 DIABETES DRUG MARKET: 360IRESEARCH FPNV POSITIONING MATRIX
FIGURE 22. GLOBAL TYPE 1 DIABETES DRUG MARKET: 360IRESEARCH MARKET SHARE ANALYSIS

List of Tables

TABLE 1. GLOBAL TYPE 1 DIABETES DRUG MARKET SIZE, 2017-2025 (USD MILLION)
TABLE 2. GLOBAL TYPE 1 DIABETES DRUG MARKET SIZE, BY FORM, 2017-2025 (USD MILLION)
TABLE 3. GLOBAL TYPE 1 DIABETES DRUG MARKET SIZE, BY INSULIN THERAPY, BY GEOGRAPHY, 2017-2025 (USD MILLION)
TABLE 4. GLOBAL TYPE 1 DIABETES DRUG MARKET SIZE, BY LONG-ACTING INSULIN, BY GEOGRAPHY, 2017-2025 (USD MILLION)
TABLE 5. GLOBAL TYPE 1 DIABETES DRUG MARKET SIZE, BY PREMIX ANALOGS, BY GEOGRAPHY, 2017-2025 (USD MILLION)
TABLE 6. GLOBAL TYPE 1 DIABETES DRUG MARKET SIZE, BY RAPID ACTING INSULIN, BY GEOGRAPHY, 2017-2025 (USD MILLION)
TABLE 7. GLOBAL TYPE 1 DIABETES DRUG MARKET SIZE, BY ORAL MEDICATION, BY GEOGRAPHY, 2017-2025 (USD MILLION)
TABLE 8. GLOBAL TYPE 1 DIABETES DRUG MARKET SIZE, BY BIGUANIDES, BY GEOGRAPHY, 2017-2025 (USD MILLION)
TABLE 9. GLOBAL TYPE 1 DIABETES DRUG MARKET SIZE, BY METFORMINE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
TABLE 10. GLOBAL TYPE 1 DIABETES DRUG MARKET SIZE, BY METFORMINE EXTENDED-RELEASE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
TABLE 11. GLOBAL TYPE 1 DIABETES DRUG MARKET SIZE, BY SODIUM GLUCOSE COTRANSPORTER 2 (SGLT2) INHIBITORS, BY GEOGRAPHY, 2017-2025 (USD MILLION)
TABLE 12. GLOBAL TYPE 1 DIABETES DRUG MARKET SIZE, BY CANAGLIFOZINE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
TABLE 13. GLOBAL TYPE 1 DIABETES DRUG MARKET SIZE, BY DAPAGLIFLOZINE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
TABLE 14. GLOBAL TYPE 1 DIABETES DRUG MARKET SIZE, BY EMPAGLIFLOZINE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
TABLE 15. GLOBAL TYPE 1 DIABETES DRUG MARKET SIZE, BY ERTUGLIFLOZINE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
TABLE 16. GLOBAL TYPE 1 DIABETES DRUG MARKET SIZE, BY END USER, 2017-2025 (USD MILLION)
TABLE 17. GLOBAL TYPE 1 DIABETES DRUG MARKET SIZE, BY DRUGSTORE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
TABLE 18. GLOBAL TYPE 1 DIABETES DRUG MARKET SIZE, BY HOSPITAL, BY GEOGRAPHY, 2017-2025 (USD MILLION)
TABLE 19. GLOBAL TYPE 1 DIABETES DRUG MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
TABLE 20. AMERICAS TYPE 1 DIABETES DRUG MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
TABLE 21. AMERICAS TYPE 1 DIABETES DRUG MARKET SIZE, BY FORM, 2017-2025 (USD MILLION)
TABLE 22. AMERICAS TYPE 1 DIABETES DRUG MARKET SIZE, BY END USER, 2017-2025 (USD MILLION)
TABLE 23. ARGENTINA TYPE 1 DIABETES DRUG MARKET SIZE, BY FORM, 2017-2025 (USD MILLION)
TABLE 24. ARGENTINA TYPE 1 DIABETES DRUG MARKET SIZE, BY END USER, 2017-2025 (USD MILLION)
TABLE 25. BRAZIL TYPE 1 DIABETES DRUG MARKET SIZE, BY FORM, 2017-2025 (USD MILLION)
TABLE 26. BRAZIL TYPE 1 DIABETES DRUG MARKET SIZE, BY END USER, 2017-2025 (USD MILLION)
TABLE 27. CANADA TYPE 1 DIABETES DRUG MARKET SIZE, BY FORM, 2017-2025 (USD MILLION)
TABLE 28. CANADA TYPE 1 DIABETES DRUG MARKET SIZE, BY END USER, 2017-2025 (USD MILLION)
TABLE 29. MEXICO TYPE 1 DIABETES DRUG MARKET SIZE, BY FORM, 2017-2025 (USD MILLION)
TABLE 30. MEXICO TYPE 1 DIABETES DRUG MARKET SIZE, BY END USER, 2017-2025 (USD MILLION)
TABLE 31. UNITED STATES TYPE 1 DIABETES DRUG MARKET SIZE, BY FORM, 2017-2025 (USD MILLION)
TABLE 32. UNITED STATES TYPE 1 DIABETES DRUG MARKET SIZE, BY END USER, 2017-2025 (USD MILLION)
TABLE 33. ASIA-PACIFIC TYPE 1 DIABETES DRUG MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
TABLE 34. ASIA-PACIFIC TYPE 1 DIABETES DRUG MARKET SIZE, BY FORM, 2017-2025 (USD MILLION)
TABLE 35. ASIA-PACIFIC TYPE 1 DIABETES DRUG MARKET SIZE, BY END USER, 2017-2025 (USD MILLION)
TABLE 36. AUSTRALIA TYPE 1 DIABETES DRUG MARKET SIZE, BY FORM, 2017-2025 (USD MILLION)
TABLE 37. AUSTRALIA TYPE 1 DIABETES DRUG MARKET SIZE, BY END USER, 2017-2025 (USD MILLION)
TABLE 38. CHINA TYPE 1 DIABETES DRUG MARKET SIZE, BY FORM, 2017-2025 (USD MILLION)
TABLE 39. CHINA TYPE 1 DIABETES DRUG MARKET SIZE, BY END USER, 2017-2025 (USD MILLION)
TABLE 40. INDIA TYPE 1 DIABETES DRUG MARKET SIZE, BY FORM, 2017-2025 (USD MILLION)
TABLE 41. INDIA TYPE 1 DIABETES DRUG MARKET SIZE, BY END USER, 2017-2025 (USD MILLION)
TABLE 42. INDONESIA TYPE 1 DIABETES DRUG MARKET SIZE, BY FORM, 2017-2025 (USD MILLION)
TABLE 43. INDONESIA TYPE 1 DIABETES DRUG MARKET SIZE, BY END USER, 2017-2025 (USD MILLION)
TABLE 44. JAPAN TYPE 1 DIABETES DRUG MARKET SIZE, BY FORM, 2017-2025 (USD MILLION)
TABLE 45. JAPAN TYPE 1 DIABETES DRUG MARKET SIZE, BY END USER, 2017-2025 (USD MILLION)
TABLE 46. MALAYSIA TYPE 1 DIABETES DRUG MARKET SIZE, BY FORM, 2017-2025 (USD MILLION)
TABLE 47. MALAYSIA TYPE 1 DIABETES DRUG MARKET SIZE, BY END USER, 2017-2025 (USD MILLION)
TABLE 48. PHILIPPINES TYPE 1 DIABETES DRUG MARKET SIZE, BY FORM, 2017-2025 (USD MILLION)
TABLE 49. PHILIPPINES TYPE 1 DIABETES DRUG MARKET SIZE, BY END USER, 2017-2025 (USD MILLION)
TABLE 50. SOUTH KOREA TYPE 1 DIABETES DRUG MARKET SIZE, BY FORM, 2017-2025 (USD MILLION)
TABLE 51. SOUTH KOREA TYPE 1 DIABETES DRUG MARKET SIZE, BY END USER, 2017-2025 (USD MILLION)
TABLE 52. THAILAND TYPE 1 DIABETES DRUG MARKET SIZE, BY FORM, 2017-2025 (USD MILLION)
TABLE 53. THAILAND TYPE 1 DIABETES DRUG MARKET SIZE, BY END USER, 2017-2025 (USD MILLION)
TABLE 54. EUROPE, MIDDLE EAST & AFRICA TYPE 1 DIABETES DRUG MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
TABLE 55. EUROPE, MIDDLE EAST & AFRICA TYPE 1 DIABETES DRUG MARKET SIZE, BY FORM, 2017-2025 (USD MILLION)
TABLE 56. EUROPE, MIDDLE EAST & AFRICA TYPE 1 DIABETES DRUG MARKET SIZE, BY END USER, 2017-2025 (USD MILLION)
TABLE 57. FRANCE TYPE 1 DIABETES DRUG MARKET SIZE, BY FORM, 2017-2025 (USD MILLION)
TABLE 58. FRANCE TYPE 1 DIABETES DRUG MARKET SIZE, BY END USER, 2017-2025 (USD MILLION)
TABLE 59. GERMANY TYPE 1 DIABETES DRUG MARKET SIZE, BY FORM, 2017-2025 (USD MILLION)
TABLE 60. GERMANY TYPE 1 DIABETES DRUG MARKET SIZE, BY END USER, 2017-2025 (USD MILLION)
TABLE 61. ITALY TYPE 1 DIABETES DRUG MARKET SIZE, BY FORM, 2017-2025 (USD MILLION)
TABLE 62. ITALY TYPE 1 DIABETES DRUG MARKET SIZE, BY END USER, 2017-2025 (USD MILLION)
TABLE 63. NETHERLANDS TYPE 1 DIABETES DRUG MARKET SIZE, BY FORM, 2017-2025 (USD MILLION)
TABLE 64. NETHERLANDS TYPE 1 DIABETES DRUG MARKET SIZE, BY END USER, 2017-2025 (USD MILLION)
TABLE 65. QATAR TYPE 1 DIABETES DRUG MARKET SIZE, BY FORM, 2017-2025 (USD MILLION)
TABLE 66. QATAR TYPE 1 DIABETES DRUG MARKET SIZE, BY END USER, 2017-2025 (USD MILLION)
TABLE 67. RUSSIA TYPE 1 DIABETES DRUG MARKET SIZE, BY FORM, 2017-2025 (USD MILLION)
TABLE 68. RUSSIA TYPE 1 DIABETES DRUG MARKET SIZE, BY END USER, 2017-2025 (USD MILLION)
TABLE 69. SAUDI ARABIA TYPE 1 DIABETES DRUG MARKET SIZE, BY FORM, 2017-2025 (USD MILLION)
TABLE 70. SAUDI ARABIA TYPE 1 DIABETES DRUG MARKET SIZE, BY END USER, 2017-2025 (USD MILLION)
TABLE 71. SOUTH AFRICA TYPE 1 DIABETES DRUG MARKET SIZE, BY FORM, 2017-2025 (USD MILLION)
TABLE 72. SOUTH AFRICA TYPE 1 DIABETES DRUG MARKET SIZE, BY END USER, 2017-2025 (USD MILLION)
TABLE 73. SPAIN TYPE 1 DIABETES DRUG MARKET SIZE, BY FORM, 2017-2025 (USD MILLION)
TABLE 74. SPAIN TYPE 1 DIABETES DRUG MARKET SIZE, BY END USER, 2017-2025 (USD MILLION)
TABLE 75. UNITED ARAB EMIRATES TYPE 1 DIABETES DRUG MARKET SIZE, BY FORM, 2017-2025 (USD MILLION)
TABLE 76. UNITED ARAB EMIRATES TYPE 1 DIABETES DRUG MARKET SIZE, BY END USER, 2017-2025 (USD MILLION)
TABLE 77. UNITED KINGDOM TYPE 1 DIABETES DRUG MARKET SIZE, BY FORM, 2017-2025 (USD MILLION)
TABLE 78. UNITED KINGDOM TYPE 1 DIABETES DRUG MARKET SIZE, BY END USER, 2017-2025 (USD MILLION)
TABLE 79. GLOBAL TYPE 1 DIABETES DRUG MARKET: SCORES
TABLE 80. GLOBAL TYPE 1 DIABETES DRUG MARKET: BUSINESS STRATEGY
TABLE 81. GLOBAL TYPE 1 DIABETES DRUG MARKET: PRODUCT SATISFACTION
TABLE 82. GLOBAL TYPE 1 DIABETES DRUG MARKET: RANKING
TABLE 83. GLOBAL TYPE 1 DIABETES DRUG MARKET: MERGER & ACQUISITION
TABLE 84. GLOBAL TYPE 1 DIABETES DRUG MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 85. GLOBAL TYPE 1 DIABETES DRUG MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 86. GLOBAL TYPE 1 DIABETES DRUG MARKET: INVESTMENT & FUNDING
TABLE 87. GLOBAL TYPE 1 DIABETES DRUG MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 88. GLOBAL TYPE 1 DIABETES DRUG MARKET: EDITION DETAILS
TABLE 89. GLOBAL TYPE 1 DIABETES DRUG MARKET: LICENSE DETAILS
TABLE 90. GLOBAL TYPE 1 DIABETES DRUG MARKET: PRICING DETAILS

Companies Mentioned

Astellas Pharma Inc.
Astrazeneca Plc
B.braun Melsungen Ag
Biocon Limited
Biodel, Inc.
Diavacs, Inc.
Janssen Pharmaceutica
Macrogenics, Inc.
Merck & Co., Inc.
Mylan N.V.
Novo Nordisk A/s
Samsung Bioepis Co., Ltd.
Sanofi S.A.